Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Enanta Pharmaceuticals Stock Price (Quote) NASDAQ:ENTA
$47.27 ( 0.77% ) Thursday, 30th Jun 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $38.40 | $48.32 | Thursday, 30th Jun 2022 ENTA stock ended at $47.27. This is 0.77% more than the trading day before Wednesday, 29th Jun 2022. During the day the stock fluctuated 6.03% from a day low at $45.57 to a day high of $48.32. |
| 90 days | $37.59 | $79.50 | |
| 52 weeks | $37.59 | $102.00 |
Historical Enanta Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2022-06-30 | $46.05 | $48.32 | $45.57 | $47.27 | 238 804 |
| 2022-06-29 | $44.55 | $47.72 | $43.96 | $46.91 | 225 564 |
| 2022-06-28 | $44.96 | $45.54 | $42.96 | $44.55 | 430 941 |
| 2022-06-27 | $44.81 | $45.64 | $43.14 | $45.24 | 232 638 |
| 2022-06-24 | $46.38 | $46.57 | $43.00 | $45.01 | 345 599 |
| 2022-06-23 | $42.00 | $45.85 | $41.95 | $45.67 | 617 408 |
| 2022-06-22 | $41.52 | $43.08 | $40.36 | $41.49 | 374 630 |
| 2022-06-21 | $41.04 | $42.28 | $40.16 | $40.30 | 321 314 |
| 2022-06-17 | $40.38 | $42.54 | $40.38 | $40.75 | 765 721 |
| 2022-06-16 | $38.90 | $39.94 | $38.52 | $39.80 | 262 975 |
| 2022-06-15 | $40.46 | $40.90 | $39.27 | $40.00 | 329 707 |
| 2022-06-14 | $40.07 | $41.49 | $39.22 | $40.02 | 310 854 |
| 2022-06-13 | $40.03 | $40.54 | $38.41 | $39.70 | 308 112 |
| 2022-06-10 | $43.06 | $43.08 | $40.86 | $40.86 | 293 424 |
| 2022-06-09 | $43.36 | $44.79 | $42.19 | $43.85 | 202 498 |
| 2022-06-08 | $43.06 | $44.97 | $42.88 | $43.43 | 114 744 |
| 2022-06-07 | $41.41 | $43.65 | $41.31 | $43.49 | 206 445 |
| 2022-06-06 | $43.56 | $43.56 | $40.82 | $41.47 | 189 349 |
| 2022-06-03 | $41.23 | $43.40 | $41.00 | $43.32 | 214 646 |
| 2022-06-02 | $39.89 | $41.61 | $38.93 | $41.27 | 118 499 |
| 2022-06-01 | $40.98 | $41.80 | $39.42 | $40.22 | 418 250 |
| 2022-05-31 | $39.39 | $40.49 | $38.40 | $39.93 | 352 327 |
| 2022-05-27 | $38.23 | $40.48 | $37.59 | $39.47 | 277 498 |
| 2022-05-26 | $39.18 | $39.26 | $37.94 | $38.13 | 250 137 |
| 2022-05-25 | $39.08 | $39.87 | $37.63 | $38.72 | 235 119 |
| 2022-05-24 | $42.59 | $43.39 | $38.85 | $39.23 | 330 776 |
| 2022-05-23 | $42.31 | $42.96 | $41.68 | $42.47 | 312 272 |
| 2022-05-20 | $44.09 | $44.52 | $39.36 | $41.87 | 500 937 |
| 2022-05-19 | $38.02 | $44.38 | $38.02 | $44.01 | 1 399 035 |
| 2022-05-18 | $47.73 | $49.35 | $44.85 | $45.97 | 356 442 |
| 2022-05-17 | $49.93 | $50.00 | $47.44 | $49.03 | 296 542 |
| 2022-05-16 | $49.88 | $50.98 | $48.75 | $48.77 | 132 578 |
| 2022-05-13 | $51.64 | $51.72 | $49.12 | $49.88 | 272 415 |
| 2022-05-12 | $50.77 | $53.22 | $49.07 | $50.43 | 453 037 |
| 2022-05-11 | $56.90 | $57.61 | $50.81 | $51.50 | 273 980 |
| 2022-05-10 | $55.44 | $58.24 | $53.70 | $56.38 | 336 877 |
| 2022-05-09 | $56.47 | $58.06 | $52.31 | $52.93 | 344 293 |
| 2022-05-06 | $58.40 | $60.26 | $56.72 | $57.46 | 248 969 |
| 2022-05-05 | $62.27 | $62.27 | $59.02 | $59.58 | 167 421 |
| 2022-05-04 | $63.58 | $63.58 | $59.71 | $62.38 | 228 794 |
| 2022-05-03 | $63.84 | $64.60 | $62.45 | $62.95 | 120 278 |
| 2022-05-02 | $64.10 | $66.08 | $61.60 | $64.16 | 246 876 |
| 2022-04-29 | $66.85 | $67.74 | $63.98 | $64.40 | 156 489 |
| 2022-04-28 | $67.30 | $67.69 | $63.83 | $67.04 | 134 123 |
| 2022-04-27 | $66.17 | $66.96 | $64.89 | $66.10 | 108 139 |
| 2022-04-26 | $69.79 | $70.60 | $65.16 | $65.67 | 232 391 |
| 2022-04-25 | $68.98 | $70.08 | $67.86 | $70.00 | 111 532 |
| 2022-04-22 | $69.58 | $70.59 | $68.64 | $68.98 | 60 783 |
| 2022-04-21 | $76.62 | $76.62 | $70.16 | $70.18 | 170 000 |
| 2022-04-20 | $73.52 | $76.64 | $72.64 | $75.79 | 196 100 |
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company focuses on discovering and developing small molecule drugs for the treatment of viral infections and liver diseases. The companys research and development focuses on four disease targets: Hepatitis C virus (HCV), Hepatitis B virus (HBV), Non-alcoholic Steatohepatitis (NASH), and Respiratory Syncytial Virus (RSV). Its lead product is paritaprevir, a protease i... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
